Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics
Fernando Bessone, Nelia Hernández, Mario Tanno, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 03, pp. 331-348
Closed Access | Times Cited: 19

Showing 19 citing articles:

Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
Meng Li, Qiong Luo, Yanyan Tao, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 59
UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis
Fernando Bessone, Geraldine L. Hillotte, Natalia Ahumada, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 01, pp. 001-022
Closed Access | Times Cited: 5
Cholangiocyte organoids to study drug-induced injury
Zhenguo Wang, Xing Chen, Luc J. W. van der Laan, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic Mechanisms
Fernando Bessone, Geraldine L. Hillotte, Norberto Tamagnone, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Drug induced cholestatic liver diseases
Einar S. Björnsson, Harshad Devarbhavi
Hepatology (2024)
Closed Access | Times Cited: 3
Histopathological Features Predicting Long-term Clinical Outcomes in Patients with Vanishing Bile Duct Syndrome
Tingting Lv, Haitian Yu, Xiao Han, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 4
Cloxacillin‐induced acute vanishing bile duct syndrome: A case study and literature review
Kyrillos Faragalla, Helena Lau, Hanlin L. Wang, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 10, pp. 4633-4638
Open Access | Times Cited: 5
Key CT and MRI findings of drug-associated hepatobiliary and pancreatic disorders
Shintaro Ichikawa, Satoshi Goshima
Japanese Journal of Radiology (2023) Vol. 42, Iss. 3, pp. 235-245
Open Access | Times Cited: 2
Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis
Jianglin Wang, Shengfeng Wang, Cuifang Wu, et al.
Infection (2023) Vol. 52, Iss. 3, pp. 891-899
Closed Access | Times Cited: 2
Nonsteroidal anti-inflammatory drugs-associated vanishing bile duct syndrome: a real-world retrospective and disproportionality analysis
Jianglin Wang, Cuifang Wu, Zhenzhen Deng
Expert Opinion on Drug Safety (2024), pp. 1-7
Closed Access
Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis
Wan-Chen Lin, Tyng‐Shiuan Hsieh, Chia‐Yu Chu
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
review on cardio-hepatic toxic macrolide: Azythromycin
Aparna Sadhu, Dipsikha Manna, Susmita Datta, et al.
International Journal of Health Sciences (2024) Vol. 8, Iss. S1, pp. 854-865
Open Access
Glucocorticoid efficacy and treatment strategies for drug-induced liver injury: a literature review
Punan Wang, Guanya Guo, Shuangshuang Jiang, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Clinicopathologic Features of a Rare and Underrecognized Variant of Early-stage Primary Biliary Cholangitis With Ductopenia
Haitian Yu, Tingting Lv, Shuxiang Li, et al.
The American Journal of Surgical Pathology (2024)
Closed Access
Severe Azithromycin-Induced Liver Injury With Vanishing Bile Duct Syndrome Necessitating Liver Transplantation
Makeda Dawkins, Tzvi Fishkin, Gavriel Berman, et al.
Annals of Internal Medicine Clinical Cases (2023) Vol. 2, Iss. 12
Open Access | Times Cited: 1
Icteric Variant of Stauffer Syndrome as a Paraneoplastic Manifestation of Type 1 Papillary Renal Cell Carcinoma
Juan Sordá, Fernando J. Barreyro, German Rojas, et al.
ACG Case Reports Journal (2023) Vol. 10, Iss. 8, pp. e01111-e01111
Open Access
Cholangiocyte Organoids to Model Chlorpromazine-Induced Bile Duct Injury
Zhenguo Wang, Xing Chen, Luc J. W. van der Laan, et al.
Research Square (Research Square) (2023)
Open Access
Cloxacillin-induced acute vanishing bile duct syndrome: a case study and literature review
Kyrillos Faragalla, Helena Lau, Hanlin Wang, et al.
Authorea (Authorea) (2022)
Open Access
Histopathological features predicated long-term clinical outcomes in patients with vanishing bile duct syndrome
Tingting Lv, Haitian Yu, Xiao Han, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top